Inventor · disambiguated record
Christine Schmitt
Also filed as: SCHMITT CHRISTINE
10 granted patents·9 pending applications·20 citations·filing 1993–2017
83Inventor score
Files withBASF SE4HUBSCHWERLEN CHRISTIAN4IDORSIA PHARMACEUTICALS LTD3MORPHOCHEM AG FÜR KOMBINATORISCHE CHEMIE2ACTELION PHARMACEUTICALS LTD1
Top patents by PatentIndex Score
19 records- 0187US8513231B2Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infectionsHUBSCHWERLEN CHRISTIAN·Filed 2012·Granted Aug 20, 2013·4 cites·15 claims
- 0280US8268812B2Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infectionsHUBSCHWERLEN CHRISTIAN·Filed 2011·Granted Sep 18, 2012·4 cites·17 claims
- 0376US10314823B2Substituted 1,2-dihydro-3H-pyrrolo[1,2-c]imidazol-3-one antibacterial compoundsIDORSIA PHARMACEUTICALS LTD·Filed 2016·Granted Jun 11, 2019·5 cites·39 claims
- 0457US8927429B2Chemical mechanical polishing (CMP) composition comprising a specific heteropolyacidSCHMITT CHRISTINE·Filed 2011·Granted Jan 6, 2015·1 cites·15 claims
- 0555US8501774B2Oxazolidinone-quinolone hybrid antibioticsHUBSCHWERLEN CHRISTIAN·Filed 2012·Granted Aug 6, 2013·0 cites·10 claims
- 0652US9133213B2Oxazolidinone-quinolone hybrid antibioticsMORPHOCHEM AG FÜR KOMBINATORISCHE CHEMIE·Filed 2013·Granted Sep 15, 2015·0 cites·13 claims
- 0749US2007155714A1Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infectionsMORPHOCHEM AG KOMB CHEMIE·Filed 2004·Application pending·0 cites
- 0845US8158797B2Oxazolidinone-quinolone hybrid antibioticsHUBSCHWERLEN CHRISTIAN·Filed 2004·Granted Apr 17, 2012·0 cites·11 claims
- 0944US9963408B2Process for preparing 1,3-butadiene from n-butenes by oxidative dehydrogenationBASF SE·Filed 2014·Granted May 8, 2018·0 cites·6 claims
- 1044US2016152531A1Method for producing 1,3-butadien from n-butenes by means of an oxidative dehydrogenationBASF SE·Filed 2014·Application pending·0 cites
- 1142US2014163289A1Coated Catalyst for the Oxidative Dehydrogenation of N-Butenes to ButadieneBASF SE·Filed 2013·Application pending·0 cites
- 1242US2016152530A1Method for the oxidative dehydrogenation of n-butenes to butadieneBASF SE·Filed 2014·Application pending·0 cites
- 1340US2015336992A1Oxazolidinone-quinolone hybrid antibioticsMORPHOCHEM AG FÜR KOMBINATORISCHE CHEMIE·Filed 2015·Application pending·0 cites
- 1435US2019315731A16-(buta-1,3-diyn-1-yl)benzo[d]thiazole derivativesVOLKER JOERG·Filed 2017·Application pending·0 cites
- 1535US2019031676A1Antibacterial annulated pyrrolidin-2-one derivativesIDORSIA PHARMACEUTICALS LTD·Filed 2016·Application pending·0 cites
- 1634US10106544B21,2-dihydro-3H-pyrrolo[1,2-C]imidazol-3-one derivatives and their use as antibacterial agentsIDORSIA PHARMACEUTICALS LTD·Filed 2015·Granted Oct 23, 2018·0 cites·15 claims
- 1733US6028036AOxide ceramic superconductive composite member and method for manufactureVACUUMSCHMELZE GMBH·Filed 1993·Granted Feb 22, 2000·6 cites·2 claims
- 1833US2017355687A1Antibacterial benzothiazole derivativesACTELION PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 1928US2013217231A1Chemical mechanical polishing (cmp) compositionDRESCHER BETTINA·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →